|
|
1. Pichardo SE, van Merkesteyn JP.
Bisphosphonate related
osteonecrosis of the jaws: spontaneous or dental origin?. Oral Surg Oral Med Oral Pathol Oral Radiol.
2013;116:287-92.
http://dx.doi.org/10.1016/j.oooo.2013.05.005
|
|
|
|
2. Kumar V, Shahi
AK. Nitrogen containing
bisphosphonates associated
osteonecrosis of the jaws: A review for past 10 year literature. Dent Res J (Isfahan).
2014;11:147-53.
|
|
|
|
|
3. Qi WX, Tang
LN, He AN, Yao Y, Shen
Z. Risk of osteonecrosis
of the jaw in cancer patients receiving denosumab: a
meta-analysis of seven
randomized controlled
trials. Int J Clin Oncol. 2014;19:403-10.
http://dx.doi.org/10.1007/s10147-013-0561-6
|
|
|
|
|
4. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra
B, et al. American Association of Oral and Maxillofacial Surgeons
position paper on bisphosphonate-related osteonecrosis
of the jaw - 2009 update. J Oral Maxillofac Surg. 2009;67:2-12.
|
|
|
|
|
5. Campisi G, Fedele S, Fusco V, Pizzo G, Di Fede O, Bedogni A. Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Future Oncol. 2014;10:257-75.
http://dx.doi.org/10.2217/fon.13.211
|
|
|
|
|
6. Otto S, Abu-Id MH, Fedele S, Warnke
PH, Becker ST, Kolk A, et al. Osteoporosis and bisphosphonates-related osteonecrosis
of the jaw: not just a sporadic coincidence-a multi-centre study. J Craniomaxillofac Surg.
2011;39:272-7.
http://dx.doi.org/10.1016/j.jcms.2010.05.009
|
|
|
|
|
7. Lo JC, O'Ryan FS, Gordon NP,
Yang J, Hui RL, Martin D, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac
Surg. 2010;68:243-53.
http://dx.doi.org/10.1016/j.joms.2009.03.050
|
|
|
|
|
8. Khan AA, Morrison
A, Hanley DA, Felsenberg
D, McCauley LK, O'Ryan
F, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30:3-23.
http://dx.doi.org/10.1002/jbmr.2405
|
|
|
|
|
9. Khl S, Walter C, Acham S, Pfeffer R, Lambrecht JT. Bisphosphonate-related
osteonecrosis of the jaws-a review. Oral Oncol. 2012;48:938-47.
http://dx.doi.org/10.1016/j.oraloncology.2012.03.028
|
|
|
|
|
10. Patel S, Choyee
S, Uyanne J, Nguyen
AL, Lee P, Sedghizadeh PP, et al. Non-exposed bisphosphonate-related
osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines. Oral Dis. 2012;18:625-32.
http://dx.doi.org/10.1111/j.1601-0825.2012.01911.x
|
|
|
|
|
11. Thumbigere-Math V, Tu L, Huckabay S, Dudek AZ, Lunos S, Basi DL, et al. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
Am J Clin Oncol.
2012;35:386-92.
http://dx.doi.org/10.1097/COC.0b013e3182155fcb
|
|
|
|
|
12. Lipton A, Fizazi
K, Stopeck AT, Henry DH, Brown JE, Yardley DA, et al. Superiority
of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer.
2012;48:3082-92.
http://dx.doi.org/10.1016/j.ejca.2012.08.002
|
|
|
|
|
13. Peddi P, Lopez-Olivo
MA, Pratt GF, Suarez-Almazor
ME. Denosumab in patients
with cancer and skeletal metastases: a systematic review and meta-analysis. Cancer Treat Rev. 2013;39:97-104.
http://dx.doi.org/10.1016/j.ctrv.2012.07.002
|
|
|
|
|
14. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association
of Oral and Maxillofacial Surgeons.
American Association of Oral and Maxillofacial Surgeons
position paper on medication-related osteonecrosis
of the jaw-2014 update.
J Oral Maxillofac Surg.
2014;72:1938-56.
http://dx.doi.org/10.1016/j.joms.2014.04.031
|
|
|
|
|
15. Ruggiero SL. Emerging concepts in the management and treatment of osteonecrosis
of the jaw. Oral Maxillofac Surg Clin North Am. 2013;25:11-20.
http://dx.doi.org/10.1016/j.coms.2012.10.002
|
|
|
|
|
16. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac
Surg. 2003;61:1115-7.
http://dx.doi.org/10.1016/S0278-2391(03)00720-1
|
|
|
|
|
17. Bagan JV, Jimenez
Y, Diaz JM, Murillo J, Sanchis
JM, Poveda R, et al. Osteonecrosis of the jaws in intravenous bisphosphonate
use: proposal for a modification of the clinical classification.
Oral Oncol. 2009;45:645-6.
http://dx.doi.org/10.1016/j.oraloncology.2008.05.011
|
|
|
|
|
18. Silverman SL, Landesberg R. Osteonecrosis
of the jaw and the role of bisphosphonates:
a critical review. Am
J Med. 2009;122(2 Suppl):S33-45.
http://dx.doi.org/10.1016/j.amjmed.2008.12.005
|
|
|
|
|
19. Sambrook P, Olver I, Goss A. Bisphosphonates and osteonecrosis
of the jaw. Aust Fam Physician. 2006;35:801-3.
|
|
|
|
|
20. American Association of Oral
and Maxillofacial Surgeons
position paper on bisphosphonate-related osteonecrosis
of the jaws. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis
of the Jaws, American
Association of Oral and Maxillofacial
Surgeons. J Oral Maxillofac
Surg. 2007;65:369-76.
http://dx.doi.org/10.1016/j.joms.2006.11.003
|
|
|
|
|
21. Khosla S, Burr
D, Cauley J, Dempster
DW, Ebeling PR, Felsenberg
D, et al. American Society for
Bone and Mineral Research.
Bisphosphonate-associated osteonecrosis
of the jaw: report of a task force of the American Society for Bone and Mineral Research. J
Bone Miner Res.
2007;22:1479-91.
http://dx.doi.org/10.1359/jbmr.0707onj
|
|
|
|
|
22. Khan AA, Sndor
GK, Dore E, Morrison AD, Alsahli
M, Amin F, et al. Canadian Association
of Oral and Maxillofacial Surgeons.
Canadian consensus practice
guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol.
2008;35:1391-7.
|
|
|
|
|
23. Khan AA, Sndor
GK, Dore E, Morrison AD, Alsahli
M, Amin F, et al. Canadian Taskforce
on Osteonecrosis of the Jaw. Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol.
2009;36:478-90.
http://dx.doi.org/10.3899/jrheum.080759
|
|
|
|
|
24. Colella G, Campisi
G, Fusco V. American Association of Oral and Maxillofacial Surgeons
position paper: Bisphosphonate-Related
Osteonecrosis of the
Jaws-2009 update: the
need to refine the BRONJ definition. J
Oral Maxillofac Surg.
2009;67:2698-9.
http://dx.doi.org/10.1016/j.joms.2009.07.097
|
|
|
|
|
25. Bedogni A, Fusco V, Agrillo A,
Campisi G. Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis
of the jaw (BRONJ).
Oral Dis. 2012;18:621-3.
http://dx.doi.org/10.1111/j.1601-0825.2012.01903.x
|
|
|
|
|
26. Junquera L, Gallego L. Nonexposed
bisphosphonate-related osteonecrosis
of the jaws: another clinical variant?. J Oral Maxillofac
Surg. 2008;66:1516-7.
http://dx.doi.org/10.1016/j.joms.2008.02.012
|
|
|
|
|
27. Mawardi H, Treister
N, Richardson P, Anderson K, Munshi N, Faiella RA, et al. Sinus tracts—an early sign of bisphosphonate-associated osteonecrosis
of the jaws?. J Oral Maxillofac Surg.
2009;67:593-601.
http://dx.doi.org/10.1016/j.joms.2008.09.031
|
|
|
|
|
28. Tubiana-Hulin M, Spielmann M, Roux C, Campone M, Zelek L, Gligorov J, et al. Physiopathology
and management of osteonecrosis
of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis. Crit Rev Oncol Hematol.
2009;71:12-21.
http://dx.doi.org/10.1016/j.critrevonc.2008.10.009
|
|
|
|
|
29. Margaix-Mu-oz M, Bagan J, Poveda-Roda R. Intravenous
bisphosphonate-related osteonecrosis
of the jaws: influence of coadjuvant antineoplastic treatment
and study of buccodental
condition. Med Oral
Patol Oral Cir Bucal. 2013;18:e194-200.
http://dx.doi.org/10.4317/medoral.18604
|
|
|
|
|
30. Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, et
al. Nonexposed variant
of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med.
2010;123:1060-4.
http://dx.doi.org/10.1016/j.amjmed.2010.04.033
|
|
|
|
|
31. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis
of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2006;102:433-41.
http://dx.doi.org/10.1016/j.tripleo.2006.06.004
|
|
|
|
|
32. Schiodt M, Reibel
J, Oturai P, Kofod T.
Comparison of nonexposed
and exposed bisphosphonate-induced
osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated
classification system.
Oral Surg Oral Med
Oral Pathol Oral Radiol.
2014;117:204-13.
http://dx.doi.org/10.1016/j.oooo.2013.10.010
|
|
|
|
|
33. Bianchi SD, Scoletta M, Cassione FB, Migliaretti G,
Mozzati M. Computerized
tomographic findings
in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:249-58.
http://dx.doi.org/10.1016/j.tripleo.2007.01.040
|
|
|
|
|
34. Bedogni A, Fedele S, Bedogni G, Scoletta M, Favia G, Colella G, et al. Staging of osteonecrosis of
the jaw requires computed tomography for accurate definition of the extent of bony disease. Br J Oral Maxillofac Surg.
2014;52:603-8.
http://dx.doi.org/10.1016/j.bjoms.2014.04.009
|
|
|
|
|
35. Arce K, Assael LA, Weissman JL, Markiewicz MR.
Imaging findings in bisphosphonate-related osteonecrosis
of jaws. J Oral Maxillofac
Surg. 2009;67:75-84.
http://dx.doi.org/10.1016/j.joms.2008.12.002
|
|
|
|
|
36. Morag Y, Morag-Hezroni
M, Jamadar DA, Ward BB, Jacobson JA, Zwetchkenbaum SR, et al. Bisphosphonate-related
osteonecrosis of the jaw: a pictorial review. Radiographics.
2009;29:1971-84.
http://dx.doi.org/10.1148/rg.297095050
|
|
|
|
|
37. Bagan JV, Cibrian
RM, Lopez J, Leopoldo-Rodado M, Carbonell E, Bagn L, et al. Sclerosis
in bisphosphonate-related osteonecrosis
of the jaws and its correlation with the clinical stages: study of 43 cases. Br J Oral Maxillofac
Surg. 2015;53:257-62.
http://dx.doi.org/10.1016/j.bjoms.2014.12.004
|
|
|
|
|
38. Allen MR, Pandya B, Ruggiero SL. Lack of correlation between duration of osteonecrosis
of the jaw and sequestra tissue morphology: what it tells us about the condition and what it means
for future studies. J Oral Maxillofac Surg. 2010;68:2730-4.
http://dx.doi.org/10.1016/j.joms.2010.05.090
|
|
|
|
|
39. McMahon RE, Bouquot JE, Glueck CJ, Griep JA, Adams WR, Spolnik
KJ, et al. Staging bisphosphonate-related
osteonecrosis of the jaw should include early stages of disease. J Oral Maxillofac Surg.
2007;65:1899-900.
http://dx.doi.org/10.1016/j.joms.2007.04.021
|
|
|
|
|
40. Yoneda T, Hagino
H, Sugimoto T, Ohta
H, Takahashi S, Soen
S, et al. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan
Osteoporosis Society, Japanese
Society of Periodontology,
Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial
Surgeons. J Bone Miner Metab.
2010;28:365-83.
http://dx.doi.org/10.1007/s00774-010-0162-7
|
|
|
|
|
41. Bagan JV, Hens-Aumente
E, Leopoldo-Rodado M, Poveda-Roda R, Bagan L. Bisphosphonate-related osteonecrosis
of the jaws: study of the staging system in a series
of clinical cases. Oral Oncol.
2012;48:753-7.
http://dx.doi.org/10.1016/j.oraloncology.2012.02.009
|
|
|
|
|
42. Franco S, Miccoli S, Limongelli L, Tempesta A, Favia G, Maiorano E, et al.
New dimensional staging of bisphosphonate-related
osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari. Int J Dent.
2014;2014:935657.
http://dx.doi.org/10.1155/2014/935657
|
|
|
|
|
|
|
|
|
|
|
|